NeuroOne Inc. is a Minnetonka, Minnesota–based platform technology company focused on developing advanced neuromonitoring and neuromodulating products. The company provides comprehensive neuromodulation cEEG monitoring and treatment solutions for patients suffering from epilepsy and other nerve-related disorders. Its lead product is a neurodiagnostic solution aimed at treating epilepsy, and NeuroOne is pursuing near-term FDA approval through the 510(k) submission process. NeuroOne leverages core technology in partnership with the Mayo Clinic and the University of Wisconsin. The company is led by CEO Dave Rosa. It raised $1.2M in seed funding to accelerate development of its lead product.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Mar 2017